We and others found that SMARCA4 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4) mutations were present in 7–8% of lung adenocarcinoma (LADC) patients (9,10). Here, SMARCA4 is linked to lung adenocarcinoma.